| Browse All

Invesco Biotechnology & Genome ETF (PBE)

Health | Exchange Traded Fund | NYSEArca
81.61 USD +1.04 (1.290%) ⇧ (April 17, 2026, 3:01 p.m. EDT)
Short-term: ★★★☆☆ | Long-term: ★★★☆☆ | Dividends: ★★★☆☆
Hot Take | April 11, 2026, 1:33 p.m. EDT

PBE is a biotechnology ETF with a moderate dividend yield, but its recent price movements show volatility. The ETF has experienced a dip from its 52-week high, and while there is potential for short-term momentum, the overall outlook remains cautious. Long-term investors may find it attractive due to its exposure to biotech innovation, but the dividend track record is inconsistent. Options activity suggests mixed signals, with some speculation on upward movement but also caution about potential downside.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.026402
MSTL0.027711
AutoTheta0.030021
AutoARIMA0.043622

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 43%
H-stat 12.16
Ljung-Box p 0.000
Jarque-Bera p 0.187
Excess Kurtosis -1.22
Attribute Value
Market Cap 371,325,504
Trailing P/E 19.51

As of April 11, 2026, 1:33 p.m. EDT: Options speculators are showing mixed signals. For the May 15 expiration, there is minimal activity, with a single OTM put and call at the ATM anchor. For June 18, there is more activity, with OTM calls showing higher volume and open interest, suggesting potential for upward movement. However, the September 18 expiration shows more bearish positioning with a put at the ATM anchor. The overall options data indicates a cautious outlook with some potential for short-term gains but also risk of downward pressure.

Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.11% 1.15% 0.43% 0.26%
Dividend History
Date Dividend Yield %
2026-03-23 0.082 0.107022
2025-12-22 0.420 0.505291
2025-09-22 0.234 0.334585
2025-06-23 0.130 0.207068
2025-03-24 0.034 0.051335
2024-06-24 0.008 0.012248
2024-03-18 0.024 0.037947
2023-06-20 0.014 0.022719
2020-03-23 0.029 0.070846
2018-09-24 0.002 0.003460
2017-06-16 0.215 0.504454
2017-03-17 0.056 0.133372
2016-12-16 0.121 0.299404
2016-09-16 0.028 0.067554
2015-12-18 0.308 0.638088
2015-09-18 0.137 0.257738
2015-06-19 0.123 0.211985
2014-09-19 0.043 0.096382
2014-06-20 0.234 0.548510
2009-12-18 0.076 0.489636
Additional Data
trailingAnnualDividendRate 0.57
trailingAnnualDividendYield 0.0070745493
dividendYield 1.09

Info Dump

Attribute Value
All Time High 85.73
All Time Low 10.87
Ask 81.75
Ask Size 500
Average Daily Volume10 Day 6,330
Average Daily Volume3 Month 7,624
Average Volume 7,624
Average Volume10Days 6,330
Beta3 Year 0.98
Bid 81.6
Bid Size 300
Book Value 75.349
Category Health
Crypto Tradeable 0
Currency USD
Custom Price Alert Confidence HIGH
Day High 81.86
Day Low 81.61
Dividend Yield 1.09
Eps Trailing Twelve Months 4.1830797
Esg Populated 0
Exchange PCX
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 79.7286
Fifty Day Average Change 1.8814011
Fifty Day Average Change Percent 0.023597568
Fifty Two Week Change Percent 37.9959
Fifty Two Week High 85.73
Fifty Two Week High Change -4.1200027
Fifty Two Week High Change Percent -0.048057888
Fifty Two Week Low 58.15
Fifty Two Week Low Change 23.46
Fifty Two Week Low Change Percent 0.40343934
Fifty Two Week Range 58.15 - 85.73
Financial Currency USD
First Trade Date Milliseconds 1,119,533,400,000
Five Year Average Return 0.0166995
Full Exchange Name NYSEArca
Fund Family Invesco
Fund Inception Date 1,119,484,800
Gmt Off Set Milliseconds -14,400,000
Has Pre Post Market Data 1
Language en-US
Legal Type Exchange Traded Fund
Long Business Summary The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Long Name Invesco Biotechnology & Genome ETF
Market us_market
Market Cap 371,325,504
Market State REGULAR
Max Age 86,400
Message Board Id finmb_22938466
Nav Price 80.71
Net Assets 246,445,728.0
Net Expense Ratio 0.58
Open 81.53
Previous Close 80.5705
Price Hint 2
Price To Book 1.0830934
Quote Source Name Nasdaq Real Time Price
Quote Type ETF
Region US
Regular Market Change 1.0394974
Regular Market Change Percent 1.2901711
Regular Market Day High 81.86
Regular Market Day Low 81.61
Regular Market Day Range 81.61 - 81.86
Regular Market Open 81.53
Regular Market Previous Close 80.5705
Regular Market Price 81.61
Regular Market Time 1,776,452,476
Regular Market Volume 3,216
Shares Outstanding 4,550,000
Short Name Invesco Biotechnology & Genome
Source Interval 15
Symbol PBE
Three Year Average Return 0.088151194
Total Assets 246,445,728
Tradeable 0
Trailing Annual Dividend Rate 0.57
Trailing Annual Dividend Yield 0.0070745493
Trailing P E 19.50955
Trailing Peg Ratio None
Trailing Three Month Nav Returns -3.37964
Trailing Three Month Returns -3.37964
Triggerable 1
Two Hundred Day Average 75.42725
Two Hundred Day Average Change 6.182747
Two Hundred Day Average Change Percent 0.08196966
Type Disp ETF
Volume 3,216
Yield 0.0109
Ytd Return -3.37964